Study Shows Exome IDs Key Variants that WGS Misses; Three Capture Techs Differ in Content, Efficiency | GenomeWeb

By Julia Karow

Exome sequencing picks up additional disease-related and other variants that a typical whole-genome sequencing experiment of the same sample does not, according to a recent study by a team of researchers at Stanford University, suggesting a continued role for targeted sequencing despite the falling prices for WGS.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.